Helminth therapy for organic diseases? (Q38553531)

4 September 2017

1 reference

title

Helminth therapy for organic diseases? (English)

1 reference

4 September 2017

3

Gerhard Rogler

1 reference

4 September 2017

Irina Leonardi

1

1 reference

PubMed ID

26207885

4 September 2017

Isabelle Frey

series ordinal

2

1 reference

4 September 2017

3 July 2015

1 reference

4 September 2017

Translational Research

1 reference

4 September 2017

166

1 reference

4 September 2017

6

1 reference

4 September 2017

586-601

1 reference

The effect of infections on susceptibility to autoimmune and allergic diseases

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Hay fever, hygiene, and household size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Reconstructing immune phylogeny: new perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Macrophage activation and polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Helminths as governors of immune-mediated inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Suppression of OVA-alum induced allergy by Heligmosomoides polygyrus products is MyD88-, TRIF-, regulatory T- and B cell-independent, but is associated with reduced innate lymphoid cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Helminth infection modulates the development of allergen-induced airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

AcCystatin, an immunoregulatory molecule from Angiostrongylus cantonensis, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Therapeutic potential of larval excretory/secretory proteins of the pig whipworm Trichuris suis in allergic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Parasite-induced 'nonspecific' IgE does not protect against allergic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Changes in pulmonary function and parasite burden in rats infected with Strongyloides venezuelensis concomitant with induction of allergic airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Suppression of allergic airway inflammation by helminth-induced regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

TLR2-dependent amelioration of allergic airway inflammation by parasitic nematode type II MIF in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Symptoms after ingestion of pig whipworm Trichuris suis eggs in a randomized placebo-controlled double-blind clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suisova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Infection with a Helminth Parasite Attenuates Autoimmunity through TGF- -Mediated Suppression of Th17 and Th1 Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Association between parasite infection and immune responses in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The impact of parasite infections on the course of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Impact of Schistosoma japonicum infection on collagen-induced arthritis in DBA/1 mice: a murine model of human rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Murine autoimmune arthritis is exaggerated by infection with the rat tapeworm, Hymenolepis diminuta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Taenia crassiceps infection does not influence the development of experimental rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Protective effect of an extract from Ascaris suum in experimental arthritis models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Suppression of transplant immunity in experimental trichinellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

PROLONGATION OF RAT KIDNEY ALLOGRAFT SURVIVAL BY NEMATODES1,2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Prolongation of allograft survival by Nippostrongylus brasiliensis is associated with decreased allospecific cytotoxic T lymphocyte activity and development of T cytotoxic cell type 2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Expression of Allograft Inflammatory Factor‐1 in Mouse Uterus and Poly (I:C)‐induced Fetal Resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The therapeutic potential of the recombinant antigen from Dirofilaria immitis (rDiAg) for immune-mediated pregnancy loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

A helminth glycan induces APC maturation via alternative NF-kappa B activation independent of I kappa B alpha degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The S. mansoni glycoprotein ω-1 induces Foxp3 expression in NOD mouse CD4⁺ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Reciprocal effects of Schistosoma mansoni infection on spontaneous autoimmune arthritis in IL-1 receptor antagonist-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Immunomodulation of liver injury by Ascaris suum extract in an experimental model of autoimmune hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Brugia filariasis differentially modulates persistent Helicobacter pylori gastritis in the gerbil model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Helminth co-infection in Helicobacter pylori infected INS-GAS mice attenuates gastric premalignant lesions of epithelial dysplasia and glandular atrophy and preserves colonization resistance of the stomach to lower bowel microbiota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Does the failure to acquire helminthic parasites predispose to Crohn's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Coinfection with an intestinal helminth impairs host innate immunity against Salmonella enterica serovar Typhimurium and exacerbates intestinal inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Development of fatal intestinal inflammation in MyD88 deficient mice co-infected with helminth and bacterial enteropathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium-induced colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Helminth infection enhances disease in a murine TH2 model of colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Exposure to schistosome eggs protects mice from TNBS-induced colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosoma japonicum ova maintains epithelial barrier function during experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Treatment with egg antigens of Schistosoma mansoni ameliorates experimental colitis in mice through a colonic T-cell-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Schistosoma mansoni infection but not egg antigen promotes recovery from colitis in outbred NMRI mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Intestinal nematode infection ameliorates experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through toll-like receptor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suis therapy in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Protein drug stability: a formulation challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

An enteric helminth infection protects against an allergic response to dietary antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Intestinal Helminths Protect in a Murine Model of Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Advances in metabolic profiling of experimental nematode and trematode infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Critical role of IL-25 in nematode infection-induced alterations in intestinal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Worm proteins of Schistosoma mansoni reduce the severity of experimental chronic colitis in mice by suppressing colonic proinflammatory immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.06.016

10.1016/J.TRSL.2015.06.016

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26207885